NIIGATA UNIVERSITY Patent applications |
Patent application number | Title | Published |
20150332016 | BRAIN INFORMATION PROCESSING APPARATUS AND BRAIN INFORMATION PROCESSING METHOD - Conventionally, it is impossible to detect an object to which a person feels a similar sense based on latent consciousness. Detection of an object to which a person feels a similar sense is realizable by a brain information processing apparatus using high-level brain activity information indicating a latent consciousness. The brain information processing apparatus has stored therein one or more pieces of brain information that includes brain activity information, which is information on a brain activation level, and object information, and includes: an accepting unit that accepts brain activity information; an object information acquisition unit that acquires one or more pieces of object information associated with one or more pieces of brain activity information that is approximate to the brain activity information to the extent of satisfying a predetermined condition; and an output unit that outputs the object information acquired by the object information acquisition unit. | 11-19-2015 |
20150297694 | CANCER DIAGNOSTIC AND THERAPEUTIC METHOD TARGETING MOLECULES EXPRESSED IN CANCER STEM CELLS - The present invention provides a novel method for determining cancer malignancy, a novel cancer diagnostic method, a novel method for determining prognosis, a novel vaccine for cancer treatment, and a novel vaccine for suppressing cancer metastasis. Specifically, the invention provides a cancer malignancy evaluation method that comprises the step of measuring a DDX3X expression level in a cancer tissue, and the step of evaluating malignancy of the cancer tissue by using the DDX3X expression level. | 10-22-2015 |
20140135379 | METHOD OF FIXING AND EXPRESSING PHYSIOLOGICALLY ACTIVE SUBSTANCE - The present invention provides methods for retaining and expressing physiologically active substances in a target tissue-specific-manner, by administering the physiologically active substances to target submucous tissue. Specifically, the present inventors demonstrated that, when physiologically active substances were directly administered into submucous tissues without using a carrier, the physiologically active substances were effectively and safely retained at the administration sites over long periods without loss and diffusion, and produced the effect acting in a reservoir-like fashion. The physiologically active substances administered as described above were demonstrated to produce the therapeutic effect without having an influence on organs other than the administered organ. | 05-15-2014 |
20140127233 | PHARMACEUTICAL COMPOSITION FOR TREATING ISCHEMIC EVENTS - Methods and pharmaceutical compositions for treating severe ischemic events including cerebral infarction, cardiac infarction, or pulmonary embolism, comprising a thrombolytic intervention including thrombolytic agents and an inhibitor of vascular endothelial growth factor (VEGF) receptor-mediated signal transduction are disclosed. | 05-08-2014 |
20140080950 | FUNCTIONAL-GROUP-MODIFIED CARBON MATERIAL, AND METHOD FOR PRODUCING SAME - Provided are a functional-group-modified carbon material modified with an isocyanate group or amino group, and a method for producing the material. The material is an isocyanate-group-modified carbon material in which an isocyanate group of a diisocyanate compound is bonded to a graphene-like carbon material, or an amino-group-modified carbon material in which a fragment obtained by radical-decomposing an amino-group-containing azo-type radical initiator is added to the graphene-like carbon material by radical-trapping. The method is a method for producing a functional-group-modified carbon material, including heating and stirring, in a solvent, a graphene-like carbon material, and a diisocyanate compound or an amino-group-containing azo-type radical initiator. | 03-20-2014 |
20140038292 | Tol1 FACTOR TRANSPOSASE AND DNA INTRODUCTION SYSTEM USING THE SAME - An object is to provide a Tol1 element transposase and a use thereof. Provided is a Tol1 element transposase containing (a) a protein having the amino acid sequence of SEQ ID No: 1 or (b) a protein having an amino acid sequence homologous to the amino acid sequence of SEQ ID NO: 1 and having an enzymatic activity for transferring Tol1 element. Further, provided is a polynucleotide encoding the transposase and an expression construct containing the polynucleotide therein. The present invention also provides a DNA introduction system including (a) a donor factor having such a structure that a desired DNA is inserted in a transposase gene-defected Tol1 element and (b) a helper factor containing the transposase or the polynucleotide. | 02-06-2014 |
20130310815 | FIBRIN-GEL COMPRESSION DEVICE - A compression device is provided which allows anyone to easily uniformly and thinly compress fibrin-gel without damage. A fibrin-gel compression device | 11-21-2013 |
20130292733 | CRYSTALLINE MATERIAL, AND LIGHT-EMITTING DEVICE AND WHITE LED USING SAME - A crystalline material represented by M | 11-07-2013 |
20130292609 | PHOSPHOR MANUFACTURING METHOD - A method for producing a silicate-based oxynitride phosphor, comprising a step of firing a raw material mixture while contacting the raw material mixture with a Si-containing gas containing gas phase Si to generate a silicate-based oxynitride phosphor. | 11-07-2013 |
20130284976 | METHOD FOR PRODUCING CRYSTALLINE MATERIAL - A method for producing a crystalline material comprising a step of firing a raw material mixture containing M | 10-31-2013 |
20130224252 | INTESTINE IMMUNOMODULATOR - The purpose of the present invention is to provide a better intestine immunomodulator. The intestine immunomodulator of the present invention comprises bacterial cells or a bacterial component of a | 08-29-2013 |
20120329968 | METHOD FOR PRODUCING 18F-LABELED COMPOUND AND HIGH MOLECULAR COMPOUND TO BE USED IN THE METHOD - The present invention aims at solving the problems of conventional methods for producing an | 12-27-2012 |
20120237440 | METHOD FOR PRODUCING HYDROGEN BY MEANS OF THERMOCHEMICAL WATER-SPLITTING, AND DEVICE FOR PRODUCING HYDROGEN - The disclosed method for producing hydrogen by means of thermochemical water-splitting can efficiently use solar energy obtained by means of a beam-down typed light collecting system. Further disclosed is a device for producing hydrogen. While circulating within a reactor ( | 09-20-2012 |
20120232310 | PALLADIUM CATALYST AND PROCESS FOR PRODUCTION OF BISARYL COMPOUND USING SAME - Disclosed are: a novel palladium catalyst which does not undergo leakage, can be recycled, does not require the use of any phosphorus-containing ligand, and has a high catalytic activity; and a process for producing a novel bisaryl compound using the palladium catalyst. In the production of a bisaryl compound by reacting an aromatic halide with an aromatic boronic acid in the presence of a palladium catalyst and a base, the palladium catalyst comprises a dendrimer containing a silica particle as a core and a palladium compound dissolved in an ionic liquid and supported on the dendrimer. | 09-13-2012 |
20120214949 | POLYMER, GAS SEPARATION MEMBRANE, AND PROCESS FOR PRODUCTION OF POLYMER - A polymer having a repeating unit represented by formula (1). | 08-23-2012 |
20120189631 | PHARMACEUTICAL COMPOSITION FOR TREATING ISCHEMIC EVENTS - Methods and pharmaceutical compositions for treating severe ischemic events including cerebral infarction, cardiac infarction, or pulmonary embolism, comprising a thrombolytic intervention including thrombolytic agents and an inhibitor of vascular endothelial growth factor (VEGF) receptor-mediated signal transduction are disclosed. | 07-26-2012 |
20120168912 | METHOD FOR QUANTITATIVELY EVALUATING CONCENTRATION OF ATOMIC VACANCIES EXISTING IN SILICON WAFER, METHOD FOR MANUFACTURING SILICON WAFER, AND SILICON WAFER MANUFACTURED BY THE METHOD FOR MANUFACTURING SILICON WAFER - A quantitative evaluation method, a method for manufacturing a silicon wafer, and a silicon wafer manufactured by the method, enabling more efficient evaluation of the concentration of atomic vacancies existing in a silicon wafer. The quantitative evaluation method includes steps of: oscillating, in a state in which an external magnetic field is applied to a silicon wafer ( | 07-05-2012 |
20120164667 | METHOD FOR TEST ON DIABETIC NEPHROPATHY - Provided is a test method for the detection of diabetic nephropathy at an early stage as compared to a conventional method. Specifically provided are: a test method for diabetic nephropathy, including detecting urinary podocalyxin; the test method, further including assessing diabetic nephropathy at least Stage I; a test reagent for use in the test method; and a test reagent kit for use in the test method. The present invention is based on a finding that urinary podocalyxin reflects the development and condition of diabetic nephropathy with high sensitivity at an early stage as compared to urinary albumin. | 06-28-2012 |
20120164662 | TEST METHOD ON RENAL DISEASES - Provided is a test method for the assessment of the necessity of renal biopsy in a subject to be tested, who is suspected of having a renal disease. Specifically provided are a test method for a renal disease, including using urinary podocalyxin and one or more additional markers in combination, and a test reagent for use in the test method and a test reagent kit for use in the test method. The present invention allows the discrimination of a poor prognosis group even for poor prognosis cases with no overt findings in a conventional test method, and thus allows the assessment of a renal disease, the assessment of the necessity of renal biopsy, prognostic prediction, and the like to be performed exactly. | 06-28-2012 |
20120058489 | USE OF MEGALIN IN URINE AS MARKER FOR DETECTING RENAL DISORDER - This invention provides a simple means for detecting a renal disorder, a diagnostic marker for a renal disorder that enables prognostic prediction of a renal disorder (e.g., diabetic nephropathy and IgA nephropathy) and evaluation of the degree of nephropathy at the phase of stage-II diabetic nephropathy by measuring the megalin level in urine associated with a renal disorder used for the detection means, and use of such marker. The invention also provides the use of human megalin obtained from the urine sample of a subject as a marker for detecting a renal disorder. | 03-08-2012 |
20120055658 | DEVICE FOR RECOVERING HEAT OF MOLTEN SLAG - A device for recovering heat of molten slag, having a simple structure and high heat recovery efficiency. The device includes: a fluidized bed ( | 03-08-2012 |
20110195523 | METHOD FOR MEASURING HUMAN MEGALIN - This invention provides a method for measuring human megalin that can be performed in a simpler manner within a shorter period of time than is possible with conventional techniques, and that can also quantify human megalin. This invention also provides a method that enables diagnosis of functional diseases, which are specific to cells, tissues, or organs, in a site-directed manner at an early stage. Measurement of human megalin enables detection of a disease in an organ in which megalin expression is observed. | 08-11-2011 |
20110159152 | MICROCAPSULES, METHOD OF PRODUCING THE MICROCAPSULES AND FOOD AND DRINK CONTAINING THE MICROCAPSULES - A method of producing microcapsules that comprises an emulsification step in which a fat-soluble substance and a sodium alginate aqueous solution are mixed to obtain an emulsified liquid in which there are dispersed emulsified particles composed of the fat-soluble substance and having a mean particle size of not greater than 800 nm, and a spraying step in which the emulsified liquid is sprayed into a calcium ion-containing solution to obtain microcapsules in which the emulsified particles are encapsulated. | 06-30-2011 |
20110123680 | MICROCAPSULE, PROCESS FOR PRODUCTION THEREOF, AND FOOD OR BEVERAGE CONTAINING MICROCAPSULE - The method of producing microcapsules | 05-26-2011 |
20110064844 | POULTRY DIET FOR IMPROVING TEXTURE - The present invention aims to provide a poultry diet that can soften the flesh quality of poultry meat and improve the texture, a method of producing a large amount of meat with improved texture by using the diet, and a breeding method of poultry having flesh quality with good texture, and a flesh quality softening agent for poultry to be used by addition to feed. | 03-17-2011 |
20110045588 | METHOD FOR CULTURING HUMAN PERIOSTEUM - The present invention provides a method for forcingly culturing a piece of human periosteum tissue in a shorter culture period, the method including the steps of: (1) placing a periosteum piece dissected from a patient on a culture dish containing no culture solution; (2) dropping platelet-rich plasma collected from the patient onto the surface of the periosteum piece on the culture dish and coagulating the platelet-rich plasma so as to cover the surface of the periosteum piece; (3) adding a first culture medium to the culture dish and growing the culture; and (4) growing the culture in a second culture medium containing a basic fibroblast growth factor and no platelet-rich plasma, after the step (3). | 02-24-2011 |
20110038891 | NOVEL LACTIC ACID BACTERIUM HAVING ANTI-ALLERGIC ACTIVITY, ANTI-ALLERGIC AGENT, FOOD AND PHARMACEUTICAL COMPOSITION EACH COMPRISING THE LACTIC ACID BACTERIUM, AND PROCESS FOR PRODUCTION OF THE ANTI-ALLERGIC AGENT - An object aims to develop a lactic acid bacterium having an anti-allergic activity, which can be grown by using rice, particularly polished white rice, and can be collected, cooked and ingested together with rice in such a state that the lactic acid bacterium is attached to the surface of the rice. Another object aims to develop a food composition and a pharmaceutical composition, each of which comprises rice containing the lactic acid bacterium as a material. Thus, disclosed are: a lactic acid bacterium | 02-17-2011 |
20110012060 | FLUORESCENT BODY FOR USE IN A NEAR-ULTRAVIOLET EXCITATION LIGHT-EMITTING ELEMENT - Provided is a fluorescent body for use in a near-ultraviolet excitation light-emitting element, comprising the compound given by formula (1), having part of element M | 01-20-2011 |
20100287133 | Identification Device, Identification Method, and Identification Processing Program - There are provided an identification device, an identification method and an identification processing program, which are capable of significantly reducing a processing burden. An identification device | 11-11-2010 |
20100217789 | PHYSICAL RANDOM NUMBER GENERATION METHOD AND PHYSICAL RANDOM NUMBER GENERATOR - There is provided a physical random number generation method and a physical random number generator by which safe random numbers can be obtained at high speed. The physical random number generator comprises a laser equipment which irradiates laser light, a frequency discrimination filter which discriminates frequencies of the laser light, an photodetector which converts intensity of laser light into electric signals, an on-off detector or an A/D converter which converts analogue signals output from the photodetector as a detected result into digital data. First, the laser light irradiated from the laser equipment is allowed to pass through the frequency discrimination filter. Transmitted light changes in intensity depending on frequency fluctuations of the laser light. Then, this intensity of the transmitted light is converted into electric signals by the photodetector to be converted into binary random numbers using the on-off detector or the A/D converter. Finally, the binary random number data thus generated are imported into a PC. | 08-26-2010 |
20100186512 | QUANTITATIVE EVALUATION DEVICE OF ATOMIC VACANCIES EXISTING IN SILICON WAFER, METHOD FOR THE DEVICE, SILICON WAFER MANUFACTURING METHOD, AND THIN-FILM OSCILLATOR - A quantitative evaluation device and method of an atomic vacancy, which are capable of efficiently and quantitatively evaluating an atomic vacancy existing in a silicon wafer. A quantitative evaluation device | 07-29-2010 |
20100145346 | TOTAL HIP REPLACEMENT ARTHROPLASTY SUPPORTING JIG AND ITS SYSTEM - A jig and a system for supporting artificial hip joint with which an artificial shelf can be arranged at an ideal arranging position more easily at reduced facility cost. Since existing arthroscope ( | 06-10-2010 |
20100129914 | Tol1 FACTOR TRANSPOSASE AND DNA INTRODUCTION SYSTEM USING THE SAME - An object is to provide a Tol1 element transposase and a use thereof. Provided is a Tol1 element transposase containing (a) a protein having the amino acid sequence of SEQ ID No: 1 or (b) a protein having an amino acid sequence homologous to the amino acid sequence of SEQ ID NO: 1 and having an enzymatic activity for transferring Tol1 element. Further, provided are a polynucleotide encoding the transposase and an expression construct containing the polynucleotide therein. The present invention also provides a DNA introduction system including (a) a donor factor having such a structure that a desired DNA is inserted in a transposase gene-defected Tol1 element and (b) a helper factor containing the transposase or the polynucleotide. | 05-27-2010 |
20100068709 | METHOD FOR DETERMINING A TONGUE CANCER - An object is to provide: a method for determining a tongue cancer in which the malignancy of tongue cancer can be objectively and accurately determined; a method for analyzing a tongue cancer tissue specimen; and a kit for analyzing a tongue cancer tissue specimen. There is provided: a method for determining a tongue cancer, comprising measuring mRNA quantity of an integrin family gene and a reference gene in the tongue cancer tissue specimen, and determining the malignancy of the tongue cancer based on a ratio of the mRNA quantity of the integrin family gene/the mRNA quantity of the reference gene; a method for analyzing a tongue cancer tissue specimen, comprising the steps of measuring mRNA quantity of an integrin family gene and a reference gene in the tongue cancer tissue specimen, and correlating a ratio of the mRNA quantity of the integrin family gene/the mRNA quantity of the reference gene with clinical data; and a kit for analyzing a tongue cancer tissue specimen. | 03-18-2010 |
20090217866 | METHOD FOR PRODUCING Si SINGLE CRYSTAL INGOT BY CZ METHOD - A Si single crystal having no defect region is stably grown by clearly detecting a type of a defect region or a defect free region of Si single crystal grown at a certain pulling rate profile and feeding back the data to the subsequent pulling. In the production of Si single crystal ingot by a CZ method, a concentration distribution of atomic vacancy in a cross-section of a precedent grown Si single crystal is detected by the direct observation method of atomic vacancy and then fed back to the subsequent pulling treatment to adjust a pulling rate profile of the subsequent pulling. | 09-03-2009 |
20090200473 | METHOD FOR MEASURING RADON AND THORON IN AIR - A novel method for measuring airborne radon and thoron capable of separately measuring radon and thoron with high sensitivity, having a small-sized device structure, and free of the influence from its measurement environment. In the method, by measuring Cherenkov light generated when airborne radon and thoron are adsorbed to an absorbent and then β rays emitted in process of disintegrations of radon and thoron pass through the absorbent, radon and thoron are measured. Based on a decay time of the Cherenkov light, a mixture ratio between radon and thoron is measured. As the absorbent, porous glass is preferably employed which is provided with fine pores of 0.3 to 30 nm in diameter. | 08-13-2009 |
20090117594 | METHOD FOR MEASURING HUMAN MEGALIN - This invention provides a method for measuring human megalin that can be performed in a simpler manner within a shorter period of time than is possible with conventional techniques, and that can also quantify human megalin. This invention also provides a method that enables diagnosis of functional diseases, which are specific to cells, tissues, or organs, in a site-directed manner at an early stage. Measurement of human megalin enables detection of a disease in an organ in which megalin expression is observed. | 05-07-2009 |
20090085009 | FLUORESCENT SUBSTANCE FOR LIGHT-EMITTING DIODE - A novel fluorescent substance for a light-emitting diode, emitting light of any one of three primary colors by excitation of an ultraviolet light-emitting diode. Alternatively, a novel fluorescent substance for a light-emitting diode, emitting light in a red region of a spectrum by excitation of a blue light-emitting diode. Na | 04-02-2009 |
20090064786 | QUANTITATIVE EVALUATION DEVICE AND METHOD OF ATOMIC VACANCY EXISTING IN SILICON WAFER - There is provided a quantitative evaluation device or the like of atomic vacancy existing in a silicon wafer in which the atomic vacancy concentration in the silicon wafer can be quantitatively evaluated by forming a rationalized thin-film transducer on a surface of a silicon sample without conducting an acceleration treatment for enhancing the concentration. This is characterized by comprising a magnetic force generating means | 03-12-2009 |
20080292208 | Image Processing Method, Image Processing Device and Recording Medium on Which Image Processing Program is Recorded - A method employing a statistic means to test whether or not luminance signals around a point of interest are distributed according to the same probability distribution with respect to luminance signals of respective pixels constituting the image; determining a range where the same probability distribution can be regarded as being satisfied, estimating the true luminance value of the point of interest by using the luminance data of the range. Especially when the image signals are faint to such an extent that the intensity of the luminance signal is based on the Poisson distribution, it is effective to perform a smoothing processing for each of the probability distributions of the signals and the noises by a test of a uniformity of the Poisson distribution, enabling a clear and denoised image to be obtained. | 11-27-2008 |